- Welcome
- Presentations
- Forum
- Blog
- YouTubule
- Resources
- Publications
- Guidelines
- Network
Nutrition 
Nephrology Tools 
Nephrology Self Assessment Quiz 
Ask the Experts 
Nephrology Journals 
Nephrology Books 
Prevention in Renal Disease Conference
Hits: 2382
8th Annual Prevention in Renal Disease
Toronto, Ontario, Canada
September 25-26, 2009
Westin Prince Hotel, Toronto
Please note: All content appearing below remains the property of the lecturer.
Any reproduction or rebroadcast without their consent is strictly prohibited
Any reproduction or rebroadcast without their consent is strictly prohibited
Program: Day 1
| 6:30 am | Registration and Breakfast |
| 7:00 am | BREAKFAST SYMPOSIUM SUPPORTED BY BRISTOL-MYERS SQUIBB & SANOFI-AVENTIS Chair: Dr. Patrick Parfrey Causes of Death in Chronic Kidney Disease Patients and their Prevention
|
| 7:45 am | Introduction Dimitrios G. Oreopoulos Opening Remarks – Philip Marsden |
| REVIEW OF DUAL BLOCKADE: BENEFICIAL OR HARMFUL? Chairs: Dr. Eli Friedman and Dr. Philip Marsden |
|
| 8:00 - 8:30 am | An overview of the rationale and literature review Dr. David Cherney |
| 8:30 - 9:00 am | Should we change our practice? Dr. Philip McFarlane |
| 9:00 - 9:20 am | DISCUSSION |
| 9:20 - 9:50 am | RESULTS OF A CANADIAN PREVENTION STUDY (THE CANPREVENT STUDY) Dr. Brendan Barrett |
| 9:50 - 10:00 am | DISCUSSION |
| 10:00 - 10:30 am | Coffee Break - Visit Posters |
| SIMULTANEOUS SESSIONS A: PREVENTION IN THE GERIATRIC PATIENT Chairs: Dr. Stanley Fenton & Dr. Vanita Jassal |
|
| 10:30 - 11:00 am | Pitfalls in estimating renal failure in the elderly by eGFR: Role of Proteinuria Dr. Richard Glassock |
| 11:00 - 11:30 am | Managing elderly persons with CKD stages 3-4 Dr. Vanita Jassal |
| 11:30 - 12:00 pm | Very old persons with CKD stage 5 and comorbidities: is Dialysis harmful? Dr. Eli Friedman |
| 12:00 - 12:30 pm | DISCUSSION |
| B: PREVENTION IN THE PEDIATRIC PATIENT Chair: Dr. Guido Filler |
|
| 10:30 - 11:00 am | Prenatal determinants for maximum nephron endowment at birth, thereby reducing CKD later in life. Dr. Susan Bagby |
| 11:00 - 11:30 am | The role of Vitamin D for the prevention of diabetes mellitus and diabetic nephropathy Dr. Shayne Taback |
| 11:30 - 12:00 pm | Prevention of CKD in patients with disorders of the complement system. Dr. Christopher Licht |
| 12:00 - 12:30 pm | DISCUSSION |
| 12:30 - 1:30 pm | Lunch |
| 1:30 - 3:30 pm | INTERACTIVE SESSION With Drs. Bargman, Cattran, Appel Vexing problems in lupus: Bargman Vexing problems in lupus: Appel Vexing problems in lupus: Cattran/Herzenberg |
| 3:30 - 4:00 pm | Coffee Break - Visit Posters |
| PREVENTION OF IATROGENIC NEPHROPATHIES Chairs: Dr. Edward Cole and Dr. Sandra Donnelly |
|
| 4:00 - 4:30 pm | Prevention of nephrotoxicity of immunosuppressive agents in kidney transplantation Dr. Jeffrey Zaltzman |
| 4:30 - 5:00 pm | Prevention of nephrotoxicity of the chemotherapeutic agent Dr. Robert Richardson |
| 5:00 - 5:30 pm | Renal sparing strategies in the management of RCC Dr. Antonio Finelli |
| 5:30 - 6:00 pm | DISCUSSION |
| 6:00 - 8:00 pm | Reception - Dinner |
Program: Day 2
| 7:00-8:00 am | BREAKFAST LECTURE An interactive session on ACEs/ARBs and Albuminuria Review and Implications of Clincial Studies CHAIR: Dr. Sheldon Tobe |
| The DROP Study Dr. Jordan Weinstein |
|
| IDNT and IRMA II Study Dr. Danny Sapir |
|
| The SMART Study Dr. Andrew Steele Discussion |
|
| PREVENTION IN PRIMARY GLOMERULAR DISEASE Chair: Dr. Daniel Cattran |
|
| 8:00 - 8:30 am | IgA Nephropathy Dr. John Feehally |
| 8:30 - 9:00 am | Membranous nephropathy Dr. Daniel Cattran |
| 9:00 - 9:30 am | Focal Sclerosis Dr. Jerry Appel |
| 9:30 - 10:00 am | DISCUSSION |
| 10:00 - 10:30 am | Coffee Break - Visit Posters |
| SIMULTANEOUS SESSION A: PREVENTION OF SECONDARY NEPHROPATHIES Chairs: Dr. Carl Cardella and Dr. John Dirks |
|
| 10:30 - 11:00 am | Viral infections (Hepatitis C) (including nephrotoxicity of Rx used in its treatment) Dr. Warren Kupin |
| 11:00 - 11:30 am | Viral infections (HIV) (including nephrotoxicity of Rx used for its treatment) Dr. Christina Wyatt |
| 11:30 - 12:00 pm | Paraproteinemias (myeloma - amyloidosis) Dr. Joseph Mikhael |
| 12:00 - 12:30 pm | DISCUSSION |
| B: PREVENTION IN PSYCHONEPHROLOGY Chairs: Dr. Marta Novak and Dr. Paul Kimmel |
|
| 10:30 - 11:00 am | Depression Dr. Paul Kimmel |
| 11:00 - 11:30 am | Coping with the Difficult Patient Dr. Gavril Hercz |
| 11:30 - 12:00 pm | Sleep Disorders Dr Marta Novak |
| 12:00 - 12:30 pm | DISCUSSION |
| 12:30 - 1:30 pm | Lunch |
| 1:30 - 2:30 pm | Poster Session |
| PREVENTION OF COMPLICATIONS IN THE DIALYSIS PATIENT Hemodialysis: Chair: Dr. Robert Richardson |
|
| 2:30 - 2:50 pm | Intradialytic hypotension Dr. Sandra Donnelly |
| 2:50 - 3:10 pm | Prevention of secondary Hyperparathyroidism in the Dialysis Patient: A paradigm shiftba Dr. Darryl Quarles |
| 3:10 - 3:30 pm | DISCUSSION |
| Peritoneal Dialysis: Chairs: Dr. Paul Tam and Dr. David Naimark |
|
| 3:30 - 3:50 pm | Growth of PD: Impact of home assistance Dr. Matthew Oliver |
| 3:50 - 4:10 pm | Prevention of Ultrafiltration Failure in PD Dr. Joanne Bargman |
| 4:10 - 4:30 pm | DISCUSSION |